[1]
Risch A, Plass C. Lung cancer epigenetics and genetics. Int J Cancer 2008; 123(1): 1-7.
[2]
Larsen JE, Minna JD. Molecular biology of lung cancer: Clinical implications. Clin Chest Med 2011; 32(4): 703-40.
[3]
Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol 2002; 20(1): 125-63.
[4]
Reiche EMV, Nunes SOV, Morimoto HK. Stress, depression, the immune system and cancer. Lancet Oncol 2004; 5(10): 617-25.
[5]
Ahangari G, Amirabad LM, Mozafari S, Majeidi A, Deilami GD. Investigation of 5-HT3A receptor gene expression in peripheral blood mononuclear cells of individuals who had been exposed to air pollution. Inflamm Allergy Drug Targets 2013; 12(6): 433-8.
[6]
Amirabad LM, Ahangari G, Deilami GD. Significant changes of 5-hydroxytriptamine 3A receptor gene expression in peripheral blood mononuclear cells of allergic asthmatic patients. Iran J Allergy Asthma Immunol 2014; 13(1): 33.
[7]
Vicentini LM, Cattaneo MG, Fesce R. Evidence for receptor subtype cross-talk in the mitogenic action of serotonin on human small-cell lung carcinoma cells. Eur J Pharmacol 1996; 318(2-3): 497-504.
[8]
Pinquart M, Duberstein P. Depression and cancer mortality: A meta-analysis. Psychol Med 2010; 40(11): 1797-810.
[9]
Azmitia EC. Modern views on an ancient chemical: Serotonin effects on cell proliferation, maturation and apoptosis. Brain Res Bull 2001; 56(5): 413-24.
[10]
Hannon J, Hoyer D. Molecular biology of 5-HT receptors. Behav Brain Res 2008; 195(1): 198-213.
[11]
Cogolludo A, Moreno L, Lodi F, et al. Serotonin inhibits voltage-gated K+ currents in pulmonary artery smooth muscle cells: Role of 5-HT2A receptors, caveolin-1 and KV1. 5 channel internalization. Circulat Res 2006; 98(7): 931-8.
[12]
Adayev T, Ray I, Sondhi R, Sobocki T, Banerjee P. The G protein-coupled 5-HT1A receptor causes suppression of caspase-3 through MAPK and protein kinase Cα. Biochim Biophys Acta 2003; 1640(1): 85-96.
[13]
Wu C, Sun D. GABA receptors in brain development, function and injury. Metab Brain Dis 2015; 30(2): 367-79.
[14]
Bettler B, Kaupmann K, Mosbacher J, Gassmann M. Molecular structure and physiological functions of GABAB receptors. Physiol Rev 2004; 84(3): 835-67.
[15]
Li Y-H, Liu Y, Li Y-D, et al. GABA stimulates human hepatocellular carcinoma growth through overexpressed GABAA receptor theta subunit. World J Gastroenterol 2012; 18(21): 2704.
[16]
Khan NA, Hichami A. Ionotrophic 5-hydroxytryptamine type 3 receptor activates the protein kinase C-dependent phospholipase D pathway in human T-cells. Biochem J 1999; 344(Pt 1): 199.
[17]
Young SZ, Bordey A. GABA’s control of stem and cancer cell proliferation in adult neural and peripheral niches. Physiology 2009; 24(3): 171-85.
[18]
Hejazi SH, Ahangari G, Pornour M, et al. Evaluation of gene expression changes of serotonin receptors, 5-HT3AR and 5-HT2AR as main stress factors in breast cancer patients. Asian Pac J Cancer Prev 2013; 15(11): 4455-8.
[19]
Pornour M, Ahangari GH, Hejazi S, Deezagi A. New perspective therapy of breast cancer based on selective dopamine receptor D2 agonist and antagonist effects on MCF-7 cell line. Recent Patents Anticancer Drug Discov 2015; 10(2): 214-23.
[20]
Herbert TB, Cohen S. Stress and immunity in humans: A meta-analytic review. Psychosom Med 1993; 55(4): 364-79.
[21]
Siddiqui EJ, Thompson CS, Mikhailidis DP, Mumtaz FH. The role of serotonin in tumour growth. Oncol Rep 2005; 14(6): 1593-7.
[22]
Ahangari G, Emadi Koochak S, Mohammadi Amirabad L, Derkhshan Deilami G. Investigation of 5-HT2A gene expression in PBMCs of patients with allergic asthma. Inflamm Allergy Drug Targets 2015; 14(1): 60-4.
[23]
Leonard BE. The concept of depression as a dysfunction of the immune system. Curr Immunol Rev 2010; 6(3): 205-12.
[24]
Seuwen K, Pouysségur J. Serotonin as a growth factor. Biochem Pharmacol 1990; 39(6): 985-90.
[25]
Horai T, Nishihara H, Tateishi R, Matsuda M, Hattori S. Oat-cell carcinoma of the lung simultaneously producing ACTH and serotonin. J Clin Endocrinol Metab 1973; 37(2): 212-9.
[26]
Cattaneo MG, Codignola A, Vicentini LM, Clementi F, Sher E. Nicotine stimulates a serotonergic autocrine loop in human small-cell lung carcinoma. Cancer Res 1993; 53(22): 5566-8.
[27]
Cattaneo MG, Fesce R, Vicentini LM. Mitogenic effect of serotonin in human small cell lung carcinoma cells via both 5-HT1A and 5-HT1D receptors. European J Pharmacol Mol Pharmacol 1995; 291(2): 209-11.
[28]
Cattaneo MG, Palazzi E, Bondiolotti G, Vicentini LM. 5-HT1D receptor type is involved in stimulation of cell proliferation by serotonin in human small cell lung carcinoma. European J Pharmacol Mol Pharmacol 1994; 268(3): 425-30.
[29]
Sheehan PF, Baker T, Tutton PJ, Barkla DH. Effects of histamine and 5‐hydroxytryptamine on the growth rate of xenografted human bronchogenic carcinomas. Clin Exp Pharmacol Physiol 1996; 23(6‐7): 465-71.
[30]
Pratesi G, Cervi S, Balsari A, Bondiolotti G, Vicentini L. Effect of serotonin and nicotine on the growth of a human small cell lung cancer xenograft. Anticancer Res 1996; 16(6B): 3615-9.
[31]
Zhang X, Zhang R, Zheng Y, et al. Expression of gamma-aminobutyric acid receptors on neoplastic growth and prediction of prognosis in non-small cell lung cancer. J Transl Med 2013; 11(1): 102.
[32]
Schuller HM, Al-Wadei HA, Majidi M. Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma. Carcinogenesis 2008; 29(10): 1979-85.
[33]
Al-Wadei HA, Al-Wadei MH, Schuller HM. Cooperative regulation of non-small cell lung carcinoma by nicotinic and beta-adrenergic receptors: A novel target for intervention. PLoS One 2012; 7(1)e29915
[34]
Wang T, Huang W, Chen F. Baclofen, a GABAB receptor agonist, inhibits human hepatocellular carcinoma cell growth in vitro and in vivo. Life Sci 2008; 82(9-10): 536-41.
